FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061100487> ?p ?o ?g. }

• W2061100487 endingPage "345" @default.
• W2061100487 startingPage "345" @default.
• W2061100487 abstract "To test the efficacy of a natural cytokine mixture (IRX-2), cyclophosphamide, indomethacin, and zinc to induce immune regression of squamous cell carcinoma (SCC) of the head and neck (H&N) prior to conventional therapy and to characterize the responses.A phase 2 trial was performed in 15 adults with recently diagnosed, biopsy-confirmed H&N SCC (3 with stage II disease, 6 with stage III disease, and 6 with stage IV disease). The patients were treated with 20 days of perilymphatic injections of IRX-2 (administered subcutaneously at the base of the skull) in combination with contrasuppression consisting of a low-dose infusion of cyclophosphamide (300 mg/m2), and daily oral indomethacin and zinc (StressTabs) in a 21-day cycle before surgery and/or radiotherapy. Tumor dimensions, toxic effects, and disease-free survival were monitored. The tumor sections were histologically examined after surgery, and tumor reduction, fragmentation, and lymphoid infiltration were assessed.All 15 patients responded clinically to the 21-day IRX-2 protocol: 1 with a complete response, 7 with a partial response, and 7 with a minor response. All 15 patients responded pathologically with tumor reduction (mean, 42%) and fragmentation (mean, 50%) in the histological section and increased lymphoid infiltration. The adverse effects of the IRX-2 protocol were negligible except for an allergic skin rash (n = 1) and parotiditis (n = 1). Indomethacin caused gastritis in 1 patient. Reduction of pain and ulceration and bleeding were observed in 8 and 4 patients, respectively. Four of 5 patients with lymphopenia showed increased CD3, CD4, and CD8 cell counts. After surgery (n = 13) and/or radiotherapy (n = 10) and with a mean follow-up of 17 months, 3 patients have had recurrences, 1 patient has died of disease, 1 patient has been re-treated with immunotherapy and has no evidence of disease, and 1 patient is alive with disease. Two patients died of other causes with no evidence of disease.The IRX-2 immunotherapy induced lymphocyte mobilization and infiltration in H&N SCC associated with clinical and histological tumor responses indicative of immune regression in all 15 patients. Minimal toxic effects were observed, and overall survival may have been improved. A phase 3 trial seems warranted." @default.
• W2061100487 created "2016-06-24" @default.
• W2061100487 creator A5004731702 @default.
• W2061100487 creator A5010133192 @default.
• W2061100487 creator A5031346962 @default.
• W2061100487 creator A5035547305 @default.
• W2061100487 creator A5063891488 @default.
• W2061100487 creator A5083039230 @default.
• W2061100487 date "2000-03-01" @default.
• W2061100487 modified "2023-09-27" @default.
• W2061100487 title "Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck" @default.
• W2061100487 cites W1768019140 @default.
• W2061100487 cites W1966488121 @default.
• W2061100487 cites W1974760995 @default.
• W2061100487 cites W1979148167 @default.
• W2061100487 cites W1980857927 @default.
• W2061100487 cites W1984655584 @default.
• W2061100487 cites W1989342572 @default.
• W2061100487 cites W2001675015 @default.
• W2061100487 cites W2006598591 @default.
• W2061100487 cites W2015480627 @default.
• W2061100487 cites W2023411546 @default.
• W2061100487 cites W2044215567 @default.
• W2061100487 cites W2048331497 @default.
• W2061100487 cites W2059515575 @default.
• W2061100487 cites W2064517738 @default.
• W2061100487 cites W2070156193 @default.
• W2061100487 cites W2082749571 @default.
• W2061100487 cites W2084920222 @default.
• W2061100487 cites W2107830051 @default.
• W2061100487 cites W213080353 @default.
• W2061100487 cites W2405990385 @default.
• W2061100487 cites W2417233099 @default.
• W2061100487 cites W2444471572 @default.
• W2061100487 doi "https://doi.org/10.1001/archotol.126.3.345" @default.
• W2061100487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10722007" @default.
• W2061100487 hasPublicationYear "2000" @default.
• W2061100487 type Work @default.
• W2061100487 sameAs 2061100487 @default.
• W2061100487 citedByCount "30" @default.
• W2061100487 countsByYear W20611004872012 @default.
• W2061100487 countsByYear W20611004872013 @default.
• W2061100487 countsByYear W20611004872016 @default.
• W2061100487 crossrefType "journal-article" @default.
• W2061100487 hasAuthorship W2061100487A5004731702 @default.
• W2061100487 hasAuthorship W2061100487A5010133192 @default.
• W2061100487 hasAuthorship W2061100487A5031346962 @default.
• W2061100487 hasAuthorship W2061100487A5035547305 @default.
• W2061100487 hasAuthorship W2061100487A5063891488 @default.
• W2061100487 hasAuthorship W2061100487A5083039230 @default.
• W2061100487 hasBestOaLocation W20611004871 @default.
• W2061100487 hasConcept C126322002 @default.
• W2061100487 hasConcept C197934379 @default.
• W2061100487 hasConcept C2776530083 @default.
• W2061100487 hasConcept C2776694085 @default.
• W2061100487 hasConcept C2776755627 @default.
• W2061100487 hasConcept C2776833033 @default.
• W2061100487 hasConcept C2778570526 @default.
• W2061100487 hasConcept C509974204 @default.
• W2061100487 hasConcept C71924100 @default.
• W2061100487 hasConcept C90924648 @default.
• W2061100487 hasConceptScore W2061100487C126322002 @default.
• W2061100487 hasConceptScore W2061100487C197934379 @default.
• W2061100487 hasConceptScore W2061100487C2776530083 @default.
• W2061100487 hasConceptScore W2061100487C2776694085 @default.
• W2061100487 hasConceptScore W2061100487C2776755627 @default.
• W2061100487 hasConceptScore W2061100487C2776833033 @default.
• W2061100487 hasConceptScore W2061100487C2778570526 @default.
• W2061100487 hasConceptScore W2061100487C509974204 @default.
• W2061100487 hasConceptScore W2061100487C71924100 @default.
• W2061100487 hasConceptScore W2061100487C90924648 @default.
• W2061100487 hasIssue "3" @default.
• W2061100487 hasLocation W20611004871 @default.
• W2061100487 hasLocation W20611004872 @default.
• W2061100487 hasOpenAccess W2061100487 @default.
• W2061100487 hasPrimaryLocation W20611004871 @default.
• W2061100487 hasRelatedWork W2013808387 @default.
• W2061100487 hasRelatedWork W2015945887 @default.
• W2061100487 hasRelatedWork W2019694656 @default.
• W2061100487 hasRelatedWork W2072765345 @default.
• W2061100487 hasRelatedWork W2112851763 @default.
• W2061100487 hasRelatedWork W2230522317 @default.
• W2061100487 hasRelatedWork W2384708512 @default.
• W2061100487 hasRelatedWork W2388106736 @default.
• W2061100487 hasRelatedWork W4249342726 @default.
• W2061100487 hasRelatedWork W4322722495 @default.
• W2061100487 hasVolume "126" @default.
• W2061100487 isParatext "false" @default.
• W2061100487 isRetracted "false" @default.
• W2061100487 magId "2061100487" @default.
• W2061100487 workType "article" @default.